Novo Ventures

United States
Firm Location:United States • San Francisco, California • Boston, Massachusetts • San Francisco Bay Area • Copenhagen, Denmark • United Kingdom
Novo Ventures Team
Photo of Michael Bauer, Venture Partner at Novo Ventures
Michael Bauer
Novo Ventures·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Copenhagen (Denmark)
Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Scott Beardsley, Managing Partner at Novo Ventures
Scott Beardsley
Novo Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in SF Bay Area (CA)
Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Series B), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Pre-seed), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Investors who were founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Jorge Becerril, Principal at Novo Ventures
Jorge Becerril
Novo Ventures·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Pre-seed), Investors in FinTech (Pre-seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Pharmaceuticals (Seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in FinTech (Series A), Investors in Health & Hospital Services (Series B), Investors in FinTech (Seed), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in FinTech (Pre-seed), Investors in Digital Health (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Raymond Camahort, Principal at Novo Ventures
Raymond Camahort
Novo Ventures·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Chemicals (Pre-seed), Investors in Chemicals (Series B), Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Chemicals (Series B), Investors in Chemicals (Pre-seed), Investors in Chemicals (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Ross Castillo, Associate at Novo Ventures
Ross Castillo
Novo Ventures·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Nik Economopoulos, Associate at Novo Ventures
Nik Economopoulos
Novo Ventures·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Photo of Anna Fan, Partner at Novo Ventures
Anna Fan
Novo Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in BioTech (Pre-seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Shawnalea Frazier, Principal at Novo Ventures
Shawnalea Frazier
Novo Ventures·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Photo of Kenneth Harrison, Partner at Novo Ventures
Kenneth Harrison
Novo Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Pre-seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Karen Hong, Partner at Novo Ventures
Karen Hong
Novo Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Health IT (Seed)
Photo of Heather Ludvigsen, Investor at Novo Ventures
Heather Ludvigsen
Novo Ventures·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Copenhagen (Denmark)
Investors in BioTech (Pre-seed), Investors in BioTech (Series B), Investors in FinTech (Pre-seed), Investors in BioTech (Series A), Investors in FinTech (Series B), Investors in BioTech (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Joe Markson, Associate at Novo Ventures
Joe Markson
Novo Ventures·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Pre-seed), Investors in IoT (Series B), Investors in IoT (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Series B), Investors in IoT (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in IoT (Seed), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in FinTech (Pre-seed), Investors in IoT (Pre-seed), Investors in Digital Health (Series A), Investors in FinTech (Series B), Investors in Digital Health (Seed), Investors in IoT (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Pre-seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Pre-seed), Investors in FinTech (Series A), Investors in IoT (Series A), Investors in BioTech (Series B), Investors in FinTech (Seed), Investors in Digital Health (Series B), Investors in IoT (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in FinTech (Pre-seed), Investors in BioTech (Series A), Investors in FinTech (Series B), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
NM
Nafise Masoumi
Novo Ventures·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States
Photo of Peter Moldt, Partner at Novo Ventures
Peter Moldt
Novo Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA)
Photo of Naveed Siddiqi, Partner at Novo Ventures
Naveed Siddiqi
Novo Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Photo of Eric Snyder, Principal at Novo Ventures
Eric Snyder
Novo Ventures·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Series B), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Diagnostics (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Pre-seed), Investors in Medical Devices (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Pre-seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Pre-seed), Investors in Medical Devices (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Medical Devices (Seed), Investors in Health IT (Pre-seed), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
Photo of Matthias Vinther, Senior Associate at Novo Ventures
Matthias Vinther
Novo Ventures·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Copenhagen (Denmark)
Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Pre-seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)